This inventor holds 1 USPTO granted patent. Top assignee: Hoboomlife Bio-Technology (Shenzhen) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yaying Hou: Innovator in Bioavailability Enhancement
Introduction
Yaying Hou is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biotechnology, particularly in enhancing the bioavailability of NAD+ derivatives. His innovative approach has the potential to impact various health-related applications.
Latest Patents
Yaying Hou holds a patent titled "Method for improving bioavailability of NAD+ derivatives." This patent describes a method that improves the bioavailability of an NAD+ derivative by combining a CD38 inhibitor with the NAD+ derivative in the same preparation. The method involves controlling the release of the CD38 inhibitor first, followed by the NAD+ derivative, thereby increasing the level of NAD+ in vivo.
Career Highlights
Yaying Hou is associated with Hoboomlife Bio-Technology (Shenzhen) Co., Ltd., where he continues to work on innovative solutions in biotechnology. His expertise in the field has led to advancements that could benefit various therapeutic areas.
Collaborations
Yaying Hou collaborates with notable colleagues, including Jiansheng Chen and Tong Zhang. Their combined efforts contribute to the ongoing research and development at Hoboomlife Bio-Technology.
Conclusion
Yaying Hou's work in improving the bioavailability of NAD+ derivatives showcases his innovative spirit and dedication to advancing biotechnology. His contributions are paving the way for future developments in health and wellness.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile